Evidence Accumulates Against Angiotensin-Converting Enzyme Inhibitors and Beta-Adrenergic Blockers as Important Co-factors for Anaphylactic Reactions

Paul A. Greenberger

doi:10.1016/j.jaip.2020.04.002

Evidence Accumulates Against Angiotensin-Converting Enzyme Inhibitors and Beta-Adrenergic Blockers as Important Co-factors for Anaphylactic Reactions

Paul A. Greenberger^*

^*Corresponding author for this work

Medicine, Allergy Division

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1906-1907
Number of pages	2
Journal	Journal of Allergy and Clinical Immunology: In Practice
Volume	8
Issue number	6
DOIs	https://doi.org/10.1016/j.jaip.2020.04.002
State	Published - Jun 2020

ASJC Scopus subject areas

Immunology and Allergy

Access to Document

10.1016/j.jaip.2020.04.002

Cite this

@article{4322fa2d6ad24c7aa013d756ad691bf6,

title = "Evidence Accumulates Against Angiotensin-Converting Enzyme Inhibitors and Beta-Adrenergic Blockers as Important Co-factors for Anaphylactic Reactions",

author = "Greenberger, {Paul A.}",

note = "Funding Information: This work was supported by the Ernest S. Bazley Foundation grants to Northwestern Memorial Hospital and Northwestern University. Funding Information: Conflicts of interest: The author declares that he has no relevant conflicts of interest. He does receive royalties from Wolters Kluwer for Up To Date reviews and a book royalty, research funding from the NIAID to Northwestern University, and medical legal fees for consulting. ",

year = "2020",

month = jun,

doi = "10.1016/j.jaip.2020.04.002",

language = "English (US)",

volume = "8",

pages = "1906--1907",

journal = "Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

publisher = "Elsevier",

number = "6",

}

TY - JOUR

T1 - Evidence Accumulates Against Angiotensin-Converting Enzyme Inhibitors and Beta-Adrenergic Blockers as Important Co-factors for Anaphylactic Reactions

AU - Greenberger, Paul A.

N1 - Funding Information: This work was supported by the Ernest S. Bazley Foundation grants to Northwestern Memorial Hospital and Northwestern University. Funding Information: Conflicts of interest: The author declares that he has no relevant conflicts of interest. He does receive royalties from Wolters Kluwer for Up To Date reviews and a book royalty, research funding from the NIAID to Northwestern University, and medical legal fees for consulting.

PY - 2020/6

Y1 - 2020/6

UR - http://www.scopus.com/inward/record.url?scp=85085658343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85085658343&partnerID=8YFLogxK

U2 - 10.1016/j.jaip.2020.04.002

DO - 10.1016/j.jaip.2020.04.002

M3 - Editorial

C2 - 32499036

AN - SCOPUS:85085658343

VL - 8

SP - 1906

EP - 1907

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

SN - 2213-2198

IS - 6

ER -

Evidence Accumulates Against Angiotensin-Converting Enzyme Inhibitors and Beta-Adrenergic Blockers as Important Co-factors for Anaphylactic Reactions

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this